These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 38028758)

  • 1. Not all kidney cysts are created equal: a distinct renal cystogenic mechanism in tuberous sclerosis complex (TSC).
    Soleimani M
    Front Physiol; 2023; 14():1289388. PubMed ID: 38028758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney intercalated cells and the transcription factor FOXi1 drive cystogenesis in tuberous sclerosis complex.
    Barone S; Zahedi K; Brooks M; Henske EP; Yang Y; Zhang E; Bissler JJ; Yu JJ; Soleimani M
    Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33536341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic Anhydrase 2 Deletion Delays the Growth of Kidney Cysts Whereas Foxi1 Deletion Completely Abrogates Cystogenesis in TSC.
    Barone S; Zahedi K; Brooks M; Soleimani M
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an Electrogenic 2Cl
    Barone S; Brooks M; Zahedi K; Holliday LS; Bissler J; Yu JJ; Soleimani M
    Am J Pathol; 2023 Feb; 193(2):191-200. PubMed ID: 36336066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
    Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
    Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal disease in tuberous sclerosis complex: pathogenesis and therapy.
    Lam HC; Siroky BJ; Henske EP
    Nat Rev Nephrol; 2018 Nov; 14(11):704-716. PubMed ID: 30232410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway.
    Hartman TR; Liu D; Zilfou JT; Robb V; Morrison T; Watnick T; Henske EP
    Hum Mol Genet; 2009 Jan; 18(1):151-63. PubMed ID: 18845692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1.
    Zhou J; Brugarolas J; Parada LF
    Hum Mol Genet; 2009 Nov; 18(22):4428-41. PubMed ID: 19692352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A large TSC2 and PKD1 gene deletion is associated with renal and extrarenal signs of autosomal dominant polycystic kidney disease.
    Longa L; Scolari F; Brusco A; Carbonara C; Polidoro S; Valzorio B; Riegler P; Migone N; Maiorca R
    Nephrol Dial Transplant; 1997 Sep; 12(9):1900-7. PubMed ID: 9306341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
    Stepanova V; Dergilev KV; Holman KR; Parfyonova YV; Tsokolaeva ZI; Teter M; Atochina-Vasserman EN; Volgina A; Zaitsev SV; Lewis SP; Zabozlaev FG; Obraztsova K; Krymskaya VP; Cines DB
    J Biol Chem; 2017 Dec; 292(50):20528-20543. PubMed ID: 28972182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal Transcriptome and Metabolome in Mice with Principal Cell-Specific Ablation of the Tsc1 Gene: Derangements in Pathways Associated with Cell Metabolism, Growth and Acid Secretion.
    Zahedi K; Barone S; Brooks M; Murray Stewart T; Casero RA; Soleimani M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic kidney disease in tuberous sclerosis complex: current knowledge and unresolved questions.
    Gallo-Bernal S; Kilcoyne A; Gee MS; Paul E
    Pediatr Nephrol; 2023 Oct; 38(10):3253-3264. PubMed ID: 36445479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTOR/miR-142-3p/PRAS40 signaling cascade is critical for tuberous sclerosis complex-associated renal cystogenesis.
    Zhao S; Hao S; Zhou J; Chen X; Zhang T; Qi Z; Zhang T; Jalal S; Zhai C; Yin L; Bo Y; Teng H; Wang Y; Gao D; Zhang H; Huang L
    Cell Mol Biol Lett; 2024 Sep; 29(1):125. PubMed ID: 39333852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex.
    Wang Y; Tang S; Wu Y; Wan X; Zhou M; Li H; Zha X
    IUBMB Life; 2020 May; 72(5):965-977. PubMed ID: 31958214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis.
    Bonnet CS; Aldred M; von Ruhland C; Harris R; Sandford R; Cheadle JP
    Hum Mol Genet; 2009 Jun; 18(12):2166-76. PubMed ID: 19321600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
    Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M
    Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal organoid modeling of tuberous sclerosis complex reveals lesion features arise from diverse developmental processes.
    Pietrobon A; Yockell-Lelièvre J; Flood TA; Stanford WL
    Cell Rep; 2022 Jul; 40(1):111048. PubMed ID: 35793620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.
    Dabora SL; Jozwiak S; Franz DN; Roberts PS; Nieto A; Chung J; Choy YS; Reeve MP; Thiele E; Egelhoff JC; Kasprzyk-Obara J; Domanska-Pakiela D; Kwiatkowski DJ
    Am J Hum Genet; 2001 Jan; 68(1):64-80. PubMed ID: 11112665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
    Plank TL; Logginidou H; Klein-Szanto A; Henske EP
    Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
    Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
    Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.